David Stapp, MD
Anatomic Pathology & Clinical Pathology · New Albany, INNPI 1053343632
Payments from drug & device makers
Across 511 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Johnson & Johnson$647
- Sanofi$636
- Regeneron Healthcare Solutions, Inc.$525
- QOL Medical, LLC$362
- plus $3K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 135 | $1,757 |
| Takeda Pharmaceuticals U.S.A., Inc. | 100 | $1,614 |
| Johnson & Johnson | 35 | $647 |
| Sanofi | 32 | $636 |
| Regeneron Healthcare Solutions, Inc. | 23 | $525 |
| QOL Medical, LLC | 18 | $362 |
| Intercept Pharmaceuticals, Inc. | 17 | $287 |
| AbbVie | 19 | $263 |
| Merck | 15 | $255 |
| Celltrion USA Inc. | 11 | $181 |
| Nestle Healthcare Nutrition Inc. | 8 | $170 |
| Phathom Pharmaceuticals, Inc. | 9 | $151 |
| Organon | 11 | $117 |
| Novo Nordisk | 6 | $113 |
| Amgen | 7 | $113 |
| Aimmune Therapeutics, Inc. | 5 | $111 |
| Shire North American Group Inc | 6 | $89 |
| Pharmacosmos Therapeutics Inc. | 5 | $81 |
| Tersera Therapeutics LLC | 4 | $81 |
| CSL Behring | 6 | $79 |
| Daiichi Sankyo Inc. | 4 | $66 |
| Madrigal Pharmaceuticals | 2 | $65 |
| Bristol Myers Squibb | 4 | $63 |
| Boston Scientific | 3 | $57 |
| Alnylam Pharmaceuticals Inc. | 3 | $51 |
| Siemens Medical Solutions USA, Inc. | 3 | $47 |
| Fresenius Kabi USA, LLC | 3 | $47 |
| Lilly USA, LLC | 3 | $45 |
| Evoke Pharma, Inc. | 3 | $38 |
| Vivus LLC | 2 | $34 |
| Romark Laboratories, LC | 1 | $25 |
| Ironwood Pharmaceuticals, Inc | 2 | $25 |
| Sandoz | 1 | $23 |
| AstraZeneca | 1 | $19 |
| Boehringer Ingelheim | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Shionogi Inc | 1 | $12 |
| UCB, Inc. | 1 | $12 |
How this compares
$8,293 in reported general payments places this provider in the 90th percentile of 137 anatomic pathology & clinical pathology providers in Indiana.
See all anatomic pathology & clinical pathology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in New Albany
- James RizzoNew Albany$554
- David RankinNew Albany$106
- Michelle ZimmermanIndianapolis$3.3M
- Carol EisenhutIndianapolis$345K
- Sunil BadveIndianapolis$314K
- Oscar CummingsIndianapolis$201K
- Jessica DavisLafayette$68K
- Michael FeldmanIndianapolis$64K
- John-Paul LavikIndianapolis$55K
- Ahmed AlomariIndianapolis$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.